Humanigen, Inc. (HGEN) financial statements (2021 and earlier)

Company profile

Business Address 533 AIRPORT BLVD.
BURLINGAME, CA 94010
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:680113841
Cash and cash equivalents680113811
Short-term investments      30
Other undisclosed cash, cash equivalents, and short-term investments 00    
Restricted cash and investments000 00 
Receivables   1   
Intangible current assets0      
Other undisclosed current assets000(1)222
Total current assets:6801251042
Noncurrent Assets
Property, plant and equipment  (0)0000
Restricted cash and investments0000000
Other noncurrent assets     0 
Other undisclosed noncurrent assets0 0   0
Total noncurrent assets:0000011
TOTAL ASSETS:6811251143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities198675 3
Accounts payable135334 2
Employee-related liabilities53331 1
Deferred revenue2 
Debt 11   11
Due to related parties 2     
Deferred revenue and credits183 0
Other undisclosed current liabilities 21   4
Total current liabilities:20148258 18
Noncurrent Liabilities
Long-term debt and lease obligation 1 11  
Long-term debt, excluding current maturities 1 11  
Liabilities, other than long-term debt2     0
Deferred revenue and credits   0
Deferred revenue2 
Other undisclosed noncurrent liabilities  1    
Total noncurrent liabilities:21111 0
Other undisclosed liabilities     5 
Total liabilities:23159269518
Stockholders' equity
Stockholders' equity attributable to parent46(14)(8)(24)(4)625
Common stock0000000
Additional paid in capital420270266238236219203
Accumulated other comprehensive loss      (0)
Accumulated deficit(374)(285)(275)(263)(241)(214)(178)
Total stockholders' equity:46(14)(8)(24)(4)625
TOTAL LIABILITIES AND EQUITY:6811251143

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:0      
Operating expenses(89)(9)(11)(19)(19)(34)(37)
Operating loss:(88)(9)(11)(19)(19)(34)(37)
Nonoperating income (expense)(0)(0)000(0)(1)
Investment income, nonoperating     0(0)
Other nonoperating income (expense)(0)(0)000(0)(0)
Interest and debt expense(1)(1)(1)(3)(0)(1)(1)
Net loss:(90)(10)(12)(22)(19)(35)(38)
Other undisclosed net income (loss) attributable to parent  (0)(0)(8) 0
Net loss available to common stockholders, diluted:(90)(10)(12)(22)(27)(35)(38)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(90)(10)(12)(22)(19)(35)(38)
Comprehensive loss:(90)(10)(12)(22)(19)(35)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (0)(0)(8)00
Comprehensive loss, net of tax, attributable to parent:(90)(10)(12)(22)(27)(35)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: